188 related articles for article (PubMed ID: 38250461)
21. Is mallory body formation a preneoplastic change? A study of 181 cases of liver bearing hepatocellular carcinoma and 82 cases of cirrhosis.
Nakanuma Y; Ohta G
Cancer; 1985 May; 55(10):2400-4. PubMed ID: 2985233
[TBL] [Abstract][Full Text] [Related]
22. Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.
Hacker HJ; Mtiro H; Bannasch P; Vesselinovitch SD
Cancer Res; 1991 Apr; 51(7):1952-8. PubMed ID: 1848480
[TBL] [Abstract][Full Text] [Related]
23. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
[TBL] [Abstract][Full Text] [Related]
24. The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.
French SW; Bardag-Gorce F; French BA; Li J; Oliva J
Exp Mol Pathol; 2011 Dec; 91(3):653-9. PubMed ID: 21820428
[TBL] [Abstract][Full Text] [Related]
25. [Preneoplastic glycogenotic lesions of the liver and kidney : Metabolic and molecular alterations in preneoplastic clear cell lesions of the liver and the kidney in experimental and human carcinogenesis].
Ribback S
Pathologe; 2020 Dec; 41(Suppl 2):83-90. PubMed ID: 33346873
[TBL] [Abstract][Full Text] [Related]
26. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
27. Loss of adenylate cyclase activity in preneoplastic and neoplastic lesions induced in rat liver by N-nitrosomorpholine.
Ehemann V; Mayer D; Hacker HJ; Bannasch P
Carcinogenesis; 1986 Apr; 7(4):567-73. PubMed ID: 3698188
[TBL] [Abstract][Full Text] [Related]
28. Expression of perilipin and adipophilin in nonalcoholic fatty liver disease; relevance to oxidative injury and hepatocyte ballooning.
Fujii H; Ikura Y; Arimoto J; Sugioka K; Iezzoni JC; Park SH; Naruko T; Itabe H; Kawada N; Caldwell SH; Ueda M
J Atheroscler Thromb; 2009; 16(6):893-901. PubMed ID: 20032580
[TBL] [Abstract][Full Text] [Related]
29. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
30. Familial non-alcoholic steatohepatitis leading to hepatocellular carcinoma.
Neuman MG; Cohen LB; Malnick S
Chem Biol Interact; 2020 May; 323():109054. PubMed ID: 32217109
[TBL] [Abstract][Full Text] [Related]
31. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma.
de Lima VM; Oliveira CP; Alves VA; Chammas MC; Oliveira EP; Stefano JT; de Mello ES; Cerri GG; Carrilho FJ; Caldwell SH
J Hepatol; 2008 Dec; 49(6):1055-61. PubMed ID: 18929425
[TBL] [Abstract][Full Text] [Related]
32. Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine.
Klimek F; Bannasch P
Carcinogenesis; 1990 Aug; 11(8):1377-80. PubMed ID: 2387024
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
34. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
[TBL] [Abstract][Full Text] [Related]
35. Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney.
Ahn YS; Zerban H; Grobholz R; Bannasch P
Carcinogenesis; 1992 Dec; 13(12):2329-34. PubMed ID: 1473241
[TBL] [Abstract][Full Text] [Related]
36. Effect of lead nitrate on liver carbohydrate enzymes and glycogen content in the rat.
Hacker HJ; Bannasch P; Columbano A
Carcinogenesis; 1990 Dec; 11(12):2199-204. PubMed ID: 2176137
[TBL] [Abstract][Full Text] [Related]
37. Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages.
Li Y; Hacker H; Kopp-Schneider A; Protzer U; Bannasch P
J Hepatol; 2002 Oct; 37(4):478-85. PubMed ID: 12217601
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground-glass cells in chronic human and woodchuck hepadnaviral infection.
Su Q; Zerban H; Otto G; Bannasch P
Hepatology; 1998 Aug; 28(2):347-59. PubMed ID: 9695996
[TBL] [Abstract][Full Text] [Related]
39. Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers.
Taketa K; Shimamura J; Ueda M; Shimada Y; Kosaka K
Cancer Res; 1988 Jan; 48(2):467-74. PubMed ID: 2825976
[TBL] [Abstract][Full Text] [Related]
40. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Du D; Liu C; Qin M; Zhang X; Xi T; Yuan S; Hao H; Xiong J
Acta Pharm Sin B; 2022 Feb; 12(2):558-580. PubMed ID: 35256934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
